Infusystem Hldgs, Inc. (INFU) Reports Q2 Loss of $0.02

Infusystem Hldgs, Inc. (NYSE: INFU) reported Q2 EPS of ($0.02).

Commenting on the second quarter, Richard DiIorio, Chief Executive Officer of InfuSystem, said, “I am pleased to announce that InfuSystem has continued to make progress on its strategic initiatives, most notably we have continued to grow sales profitably and build on our industry leadership as the “Trusted Partner for Infusion Care”. Net loss for the quarter was $0.5 million, an improvement of 54% over our second quarter 2017 net loss of $1.1 million. Adjusted EBITDA (“AEBITDA”) (a non-GAAP financial measure) was $3.2 million for the quarter and $6.7 million for the six months ended June 30, 2018 compared to $3.1 million for the prior year quarter and $4.5 million for the six months ended June 30, 2017. Total Debt was $25.2 million on June 30, 2018, compared to $32.2 million on June 30, 2017, a decrease of $7.0 million versus the prior year. Net Debt (total debt net of cash, a non-GAAP financial measure) was $22.9 million on June 30, 2018, compared to $32.1 million on June 30, 2017, a decrease of $9.2 million versus the prior year. Because of the successful reduction in net indebtedness, we have been able to begin aggressively pursuing opportunities to buy back shares, with substantial repurchases completed in recent weeks. We are focused on creating shareholder value while providing outstanding patient safety, clinical support, and biomedical service to our healthcare provider customers and our patients.”

For earnings history and earnings-related data on Infusystem Hldgs, Inc. (INFU) click here.

You May Also Be Interested In

• Nomura/Instinet Upgrades Genting Singapore (GENS:SP) (GIGNY) to Neutral
• Gemini Space Station, Inc. (GEMI) Misses Q2 EPS by 32c
• zSpace, Inc. (ZSPC) Reports Q2 results